Murawska M - Search Results

1

PIK3CA amplification associates with resistance to chemotherapy in ovarian cancer patients.

Kolasa IK, Rembiszewska A, Felisiak A, Ziolkowska-Seta I, Murawska M, Moes J, Timorek A, Dansonka-Mieszkowska A, Kupryjanczyk J. Kolasa IK, et al. Among authors: murawska m. Cancer Biol Ther. 2009 Jan;8(1):21-6. doi: 10.4161/cbt.8.1.7209. Epub 2009 Jan 17. Cancer Biol Ther. 2009. PMID: 19029838

2

Androgen, progesterone, and FSH receptor polymorphisms in ovarian cancer risk and outcome.

Ludwig AH, Murawska M, Panek G, Timorek A, Kupryjanczyk J. Ludwig AH, et al. Among authors: murawska m. Endocr Relat Cancer. 2009 Sep;16(3):1005-16. doi: 10.1677/ERC-08-0135. Epub 2009 May 20. Endocr Relat Cancer. 2009. PMID: 19458022

3

Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients.

Felisiak-Golabek A, Rembiszewska A, Rzepecka IK, Szafron L, Madry R, Murawska M, Napiorkowski T, Sobiczewski P, Osuch B, Kupryjanczyk J; Polish Ovarian Cancer Study Group (POCSG). Felisiak-Golabek A, et al. Among authors: murawska m. J Ovarian Res. 2011 Nov 10;4(1):20. doi: 10.1186/1757-2215-4-20. J Ovarian Res. 2011. PMID: 22075440 Free PMC article.

4

Breast cancer subtypes and response to systemic treatment after whole-brain radiotherapy in patients with brain metastases.

Niwińska A, Murawska M, Pogoda K. Niwińska A, et al. Among authors: murawska m. Cancer. 2010 Sep 15;116(18):4238-47. doi: 10.1002/cncr.25391. Cancer. 2010. PMID: 20549816 Free article.

5

Breast cancer leptomeningeal metastasis--the role of multimodality treatment.

Rudnicka H, Niwińska A, Murawska M. Rudnicka H, et al. Among authors: murawska m. J Neurooncol. 2007 Aug;84(1):57-62. doi: 10.1007/s11060-007-9340-4. Epub 2007 Feb 20. J Neurooncol. 2007. PMID: 17310266 Clinical Trial.

6

Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy.

Niwińska A, Rudnicka H, Murawska M. Niwińska A, et al. Among authors: murawska m. Clin Breast Cancer. 2015 Feb;15(1):66-72. doi: 10.1016/j.clbc.2014.07.004. Epub 2014 Aug 22. Clin Breast Cancer. 2015. PMID: 25287959

7

Analysis of pattern, time and risk factors influencing recurrence in triple-negative breast cancer patients.

Pogoda K, Niwińska A, Murawska M, Pieńkowski T. Pogoda K, et al. Among authors: murawska m. Med Oncol. 2013 Mar;30(1):388. doi: 10.1007/s12032-012-0388-4. Epub 2013 Jan 5. Med Oncol. 2013. PMID: 23292831 Free PMC article.

8

The effect of early detection of occult brain metastases in HER2-positive breast cancer patients on survival and cause of death.

Niwińska A, Tacikowska M, Murawska M. Niwińska A, et al. Among authors: murawska m. Int J Radiat Oncol Biol Phys. 2010 Jul 15;77(4):1134-9. doi: 10.1016/j.ijrobp.2009.06.030. Epub 2009 Nov 24. Int J Radiat Oncol Biol Phys. 2010. PMID: 19932944

9

New breast cancer recursive partitioning analysis prognostic index in patients with newly diagnosed brain metastases.

Niwińska A, Murawska M. Niwińska A, et al. Among authors: murawska m. Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):2065-71. doi: 10.1016/j.ijrobp.2010.10.077. Epub 2011 May 17. Int J Radiat Oncol Biol Phys. 2012. PMID: 21596487

10

RRM proteins interacting with the cap region of topoisomerase I.

Trzcińska-Daneluti AM, Górecki A, Czubaty A, Kowalska-Loth B, Girstun A, Murawska M, Lesyng B, Staroń K. Trzcińska-Daneluti AM, et al. Among authors: murawska m. J Mol Biol. 2007 Jun 15;369(4):1098-112. doi: 10.1016/j.jmb.2007.04.017. Epub 2007 Apr 12. J Mol Biol. 2007. PMID: 17481653

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

53 results

Search Page